1. 1869 Disease characteristics of subgroup patients treated with everolimus + exemestane for <12 months, ≥12 to <18months, and ≥18 months - Results of the 3rd interim analysis of the non-interventional trial BRAWO. (September 2015) Authors: Lüftner, D.; Grischke, E.M.; Fasching, P.; Decker, T.; Schneeweiss, A.; Uleer, C.; Foerster, F.; Wimberger, P.; Kluth-Pepper, B.; Schubert, J.; Bloch, W.; Tesch, H.; Schuetz, F.; Jackisch, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Extended adjuvant treatment of patients with HER2+ early breast cancer with neratinib: a multi-centric, prospective, non-interventional study (NIS) in Germany and Austria (ELEANOR). (April 2021) Authors: Bartsch, R.; Lüftner, D.; Balic, M.; Rinnerthaler, G.; Jackisch, C.; Müller, V.; Schmidt, M.; Harbeck, N. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neratinib as extended adjuvant therapy in patients with HER2-positive/HR-positive early breast cancer: German HTA-driven analyses from the ExteNET study. (April 2021) Authors: Lüftner, D.; Tesch, H.; Schmidt, M.; Hartkopf, A.; Streicher, S.; Resch, A.; Genovese, L.; Rosé, C.; Valenti, R.; Harbeck, N. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system. (October 2020) Authors: Schmidt, M.; Degenhardt, T.; Fasching, P.A.; Lüftner, D.; Müller, V.; Thomssen, C.; Schem, C.; Witzel, I.; Decker, T.; Tesch, H.; Kümmel, S.; Uleer, C.; Würstlein, R.; Hoffmann, O.; Warm, M.; Marschner, N.; Kates, R.E.; Schumacher, J.; Harbeck, N. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The interplay between interface structure, energy level alignment and chemical bonding strength at organic–metal interfaces. Issue 3 (5th December 2014) Authors: Willenbockel, M.; Lüftner, D.; Stadtmüller, B.; Koller, G.; Kumpf, C.; Soubatch, S.; Puschnig, P.; Ramsey, M. G.; Tautz, F. S. Journal: Physical chemistry chemical physics Issue: Volume 17:Issue 3(2015) Page Start: 1530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Health resource utilisation associated with skeletal‐related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study. (10th February 2016) Authors: Duran, I.; Fink, M.G.; Bahl, A.; Hoefeler, H.; Mahmood, A.; Lüftner, D.; Ghazal, H.; Wei, R.; Chung, K.C.; Hechmati, G.; Green, J.; Atchison, C. Journal: European journal of cancer care Issue: Volume 26:Number 6(2017:Nov.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study. (May 2013) Authors: Hechmati, G.; Cure, S.; Gouépo, A.; Hoefeler, H.; Lorusso, V.; Lüftner, D.; Duran, I.; Garzon-Rodriguez, C.; Ashcroft, J.; Wei, R.; Ghelani, P.; Bahl, A. Journal: Journal of medical economics Issue: Volume 16:Number 5(2013) Page Start: 691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib. (April 2023) Authors: Bartsch, R.; Harbeck, N.; Wrobel, D.; Zaiss, M.; Terhaag, J.; Guth, D.; Distelrath, A.; Wuerstlein, R.; Zahn, M.-O.; Lüftner, D.; Schwitter, M.; Balic, M.; Jackisch, C.; Müller, V.; Rinnerthaler, G.; Schmidt, M.; Zaman, K.; Schinköthe, T.; Gorray, M.; Breitenstein, U. Journal: Breast Issue: Volume 68(2023) Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Health resource utilisation associated with skeletal‐related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study. (10th February 2016) Authors: Duran, I.; Fink, M.G.; Bahl, A.; Hoefeler, H.; Mahmood, A.; Lüftner, D.; Ghazal, H.; Wei, R.; Chung, K.C.; Hechmati, G.; Green, J.; Atchison, C. Journal: European journal of cancer care Issue: Volume 26:Number 6(2017:Nov.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗